Evaluation of Intraocular Pressure Changes with Topical Dexamethasone 0.1%, Prednisolone 1% and Difluprednate 0.05% Postcataract Surgery- A Randomised Clinical Trial
- 1 July 2021
- journal article
- research article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
Abstract
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.Keywords
This publication has 7 references indexed in Scilit:
- Comparison of prednisolone acetate 1.0% and difluprednate ophthalmic emulsion 0.05% after cataract surgery: Incidence of postoperative steroid-induced ocular hypertensionJournal of Cataract & Refractive Surgery, 2017
- A retrospective analysis of intraocular pressure changes after cataract surgery with the use of prednisolone acetate 1% versus difluprednate 0.05%Clinical Ophthalmology, 2016
- Intraocular Pressure Effects of Common Topical Steroids for Post-Cataract Inflammation: Are They All the Same?Ophthalmology and Therapy, 2013
- Difluprednate ophthalmic emulsion 0.05% (Durezol®) administered two times daily for managing ocular inflammation and pain following cataract surgeryClinical Ophthalmology, 2010
- Difluprednate ophthalmic emulsion 0.05% for postoperative inflammation and painJournal of Cataract & Refractive Surgery, 2009
- Comparison of topical 0.7% dexamethasone–cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammationAlbrecht von Graefes Archiv für Ophthalmologie, 2005
- Topical Nonsteroidal Anti-Inflammatory Therapy in OphthalmologyOphthalmologica, 2003